n-methylaspartate has been researched along with glyx-13 peptide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Deyama, S; Duman, RS; Fogaça, MV; Fukumoto, K; Kato, T; Li, XY | 1 |
1 other study(ies) available for n-methylaspartate and glyx-13 peptide
Article | Year |
---|---|
BDNF release and signaling are required for the antidepressant actions of GLYX-13.
Topics: Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Depression; Ketamine; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; N-Methylaspartate; Oligopeptides; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptor, trkB; Receptors, N-Methyl-D-Aspartate; Signal Transduction | 2018 |